MapLight Therapeutics officer proposes $132K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. officer Lillie James Woodruff reported 4,896 common shares for sale, with an aggregate market value of $132,289.92; the approximate sale date is April 15, 2026. The shares are to be sold solely to satisfy tax-withholding obligations in connection with restricted stock unit (RSU) vesting.
Key Figures
Key Terms
Restricted Stock Unit Grant financial
RSU vesting financial
tax-withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What RSU grants are listed in the MPLT notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.